Search

Tuberculosis could involve every organ. CNS involvement occurs in 10-15% of patients with extra pulmonary tuberculosis. This paper presents an unusual case of tuberculoma. A 36- year-old man was referred to Qaemshahr Razi hospital with decrease in consciousness level and paraparesia. His brain MRI revealed small and multiple hyperatenuated lesions in pons, hypothalamus and temporal lobes. Analysis of CSF fluid was consistent with TB meningitis. Anti-TB drugs and prednisolone was started for the patient. His status improved and his brain MRI involvement resolved by the end of treatment. In an endemic area, tuberculosis should be considered as a differential diagnosis for patients with fever, decrease in consciousness level and neurological deficit. [ABSTRACT FROM AUTHOR]

Background and Aim The purpose of this study was to investigate the stimulatory and protective effects of Methylphenidate (MPD) on the experimental epilepsy induced by intraperitoneal injection of Pentylenetetrazole (PTZ) in adult male rats. Methods & Materials In this study, 15 male rats (weight, 200-250 gr) dividied into one control group (n=5) received normal saline and two treatment groups; the first group (n=5) received MPD with a dose of 2.5 mg/kg and the second group (n=5) received MPD with a dose of 5 mg/kg by gavage. After anesthesia with ketamine-xylazin combination and animal skull surgery, the recorded electrodes were inserted into the cranium in the stratum striatum layer of the CA1 region of the hippocampus, and epileptic activity was induced by intraperitoneal injection of PTZ (80 mg/kg) and the epileptiform activity was evaluated in terms of the number of spikes per time unit and their amplitudes by eTrace software. Ethical Considerations This study with an ethics code of FVMT.REC.1397.67 was approved by the Research Ethics Committee of the Faculty of Veterinary Medicine at University of Tabriz. Results Oral MPD at 2.5 and 5 mg/kg doses increased the number of spikes up to 576 and 613, respectively, compared to the control group (330 spikes), which were statistically significant. Amplitude of PTZinduced epileptic activity after treatment with 2.5 and 5 mg/kg MPD reached 1254 and 1085 respectively compared to control group (1051), which were not statistically significant. Conclusion The doses of oral MPD used in this study potentiate seizure activity. Therefore, the use of this drug in people with a background of seizure or suffering from some types of seizure should be cautious, and the evaluation of its effect in these patients need further studies. [ABSTRACT FROM AUTHOR]